A new high-tech vaccine manufactoring facility will be developed in Melbourne to Australia's long-term critical health products, including Q Fever, and life-saving antivenoms.

Regional Health Minister Mark Coulton said the new laboratory, which would see local production secured until 2036, helped ensure the safety of some of the nation's hardest workers.

"Australians who live and work in the bush are well aware of the dangers of Q Fever and today's announcement is sure to be welcomed far and wide," he said.

"The potentially-debilitating Q Fever bacterium (Coxiella burnetti) can be carried by both domestic and wild animals, which places many of the nation's hardest workers, from roo shooters to abattoir workers, graziers, and even greenkeepers at risk of contracting the disease with their only real protection coming in the form of vaccine.

READ MORE:

"The risk doesn't end at the work site either, with winds able to distribute contaminated dust particles far from the source.

"While people across the globe suffer from Q Fever, Australian company, Seqirus, is the only producer of the sole existing vaccine, Q Vax, which makes today's announcement all the more important as its impact will be felt abroad."

Minister Coulton added the benefit that a strengthened supply of antivenoms will help reduce the chances of regional Australians falling victim to many of the world's most venomous animals.

"Australia is known for its inhospitable wildlife, and many in the regions live with the danger they pose every day," he said.

"Producing antivenoms locally means we have the right antivenom, for the right situation, right here in Australia.

"Today's investment ensures these life-saving medicines will reach the patient when they're needed, increasing the likelihood of survival and recovery.

"Without this historic agreement, Australia would need to source these critical products from overseas."

Did you know you can receive updates straight to your inbox? To make sure you're up-to-date with news from across the region, sign up below.